More Indian Sites Under U.S. FDA Lens? Wockhardt Slapped With Import Alert On Injectables Site
This article was originally published in PharmAsia News
Executive Summary
In the wake of the Ranbaxy settlement, Wockhardt is the latest Indian company to be issued an import alert for alleged GMP violations.